SCHEMBL4414447

SCHEMBL4414447

CNC(=O)Cn1c(=O)oc2cc(Br)ccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.67
ALDH1A1 P00352 3/20 0.59
HPGD P15428 2/20 0.59
HTT P42858 2/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
CBX7 O95931 3/20 0.57
CDYL Q9Y232 3/20 0.57
CDY1; CDY1B Q9Y6F8 3/20 0.57
KMT2A Q03164 3/20 0.55
MEN1 O00255 1/20 0.55
NPC1 O15118 1/20 0.54
LMNA P02545 4/20 0.48
PKM P14618 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
GFER P55789 1/20 0.48
SIGMAR1 Q99720 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4411764 0.84 TP53 (0.61) TP53ALDH1A1HPGDKMT2AMEN1
SCHEMBL4411794 0.82 HPGD (0.64) TP53ALDH1A1HPGDHTTCRHBP
SCHEMBL4420217 0.81 TP53 (0.58) TP53ALDH1A1HPGDHTTCRHBP
SCHEMBL4427310 0.80 LMNA (0.71) TP53HPGDCBX7CDYLCDY1; CDY1B
SCHEMBL4423632 0.79 TSPO (0.57) TP53ALDH1A1HPGDHTTCRHBP
SCHEMBL4424979 0.79 KMO (0.47) TP53ALDH1A1KMT2AMEN1LMNA
SCHEMBL12061417 0.78 NPC1 (0.64) TP53ALDH1A1HPGDHTTCRHBP
SCHEMBL14689115 0.77 TSPO (0.53) HTTTSHRSMN1; SMN2MAPT
SCHEMBL4425116 0.76 KMT2A (0.66) TP53ALDH1A1KMT2AMEN1POLB
SCHEMBL4420785 0.75 HPGD (0.56) TP53ALDH1A1HPGDHTTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293775-B2 Benzoxazolone derivatives, processes for preparing them and their uses UCB PHARMA, S.A. (BE) 2012-10-23 US disclosed
EP-1756071-B1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB PHARMA SA (BE) 2009-08-26 EP disclosed
US-20070299118-A1 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses UCB, S.A. (BE) 2007-12-27 US disclosed
EP-1756071-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2007-02-28 EP disclosed
WO-2005118561-A1 BENZOXAZOLONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB, S.A. (BE) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299118-A1 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses PARK7, SNCA, GABRA5 TP53 4794/4885ALDH1A1 1139/4885HPGD 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.